This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 May;144(5):1653-5.

doi: 10.1210/en.2003-0234.

Androgen receptor: good guy or bad guy in prostate cancer invasion?

Elisabetta Baldi, Lorella Bonaccorsi, Gianni Forti

PMID: 12697667
DOI: 10.1210/en.2003-0234

Review

Androgen receptor: good guy or bad guy in prostate cancer invasion?

Elisabetta Baldi et al. Endocrinology. 2003 May.

. 2003 May;144(5):1653-5.

doi: 10.1210/en.2003-0234.

Authors

Elisabetta Baldi, Lorella Bonaccorsi, Gianni Forti

PMID: 12697667
DOI: 10.1210/en.2003-0234

Erratum in

Endocrinology. 2003 Jul;144(7):2901

No abstract available

PubMed Disclaimer

Comment on

Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer.
Liao X, Thrasher JB, Pelling J, Holzbeierlein J, Sang QX, Li B. Liao X, et al. Endocrinology. 2003 May;144(5):1656-63. doi: 10.1210/en.2002-0157. Endocrinology. 2003. PMID: 12697668

Similar articles

Androgen receptor and invasion in prostate cancer.
Hara T, Miyazaki H, Lee A, Tran CP, Reiter RE. Hara T, et al. Cancer Res. 2008 Feb 15;68(4):1128-35. doi: 10.1158/0008-5472.CAN-07-1929. Cancer Res. 2008. PMID: 18281488
[Molecules associated with invasion and metastasis in prostate cancer].
Ashida S, Inoue K, Shuin T. Ashida S, et al. Nihon Rinsho. 2016 May 20;74 Suppl 3:135-9. Nihon Rinsho. 2016. PMID: 27344717 Japanese. No abstract available.
Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
Horvath LG, Lelliott JE, Kench JG, Lee CS, Williams ED, Saunders DN, Grygiel JJ, Sutherland RL, Henshall SM. Horvath LG, et al. Prostate. 2007 Jul 1;67(10):1081-90. doi: 10.1002/pros.20607. Prostate. 2007. PMID: 17476687
Expression and function of androgen receptor in carcinoma of the prostate.
Culig Z, Hobisch A, Bartsch G, Klocker H. Culig Z, et al. Microsc Res Tech. 2000 Dec 1;51(5):447-55. doi: 10.1002/1097-0029(20001201)51:5<447::AID-JEMT7>3.0.CO;2-M. Microsc Res Tech. 2000. PMID: 11074615 Review.
Androgen receptor action in hormone-dependent and recurrent prostate cancer.
Agoulnik IU, Weigel NL. Agoulnik IU, et al. J Cell Biochem. 2006 Oct 1;99(2):362-72. doi: 10.1002/jcb.20811. J Cell Biochem. 2006. PMID: 16619264 Review.

See all similar articles

Cited by

The vitamin D analogue BXL-628 inhibits growth factor-stimulated proliferation and invasion of DU145 prostate cancer cells.
Marchiani S, Bonaccorsi L, Ferruzzi P, Crescioli C, Muratori M, Adorini L, Forti G, Maggi M, Baldi E. Marchiani S, et al. J Cancer Res Clin Oncol. 2006 Jun;132(6):408-16. doi: 10.1007/s00432-006-0086-8. Epub 2006 Feb 17. J Cancer Res Clin Oncol. 2006. PMID: 16485114 Free PMC article.
Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer.
Wang X, Chen J, Li QK, Peskoe SB, Zhang B, Choi C, Platz EA, Zhang H. Wang X, et al. Glycobiology. 2014 Oct;24(10):935-44. doi: 10.1093/glycob/cwu051. Epub 2014 Jun 5. Glycobiology. 2014. PMID: 24906821 Free PMC article.
Improvement in predicting tumorigenic phenotype of androgen-insensitive human LNCaP prostatic cancer cell subline in recombination with rat urogenital sinus mesenchyme.
Kanai M, Ishii K, Kanda H, Ogura Y, Kise H, Arima K, Sugimura Y. Kanai M, et al. Cancer Sci. 2008 Dec;99(12):2435-43. doi: 10.1111/j.1349-7006.2008.00975.x. Epub 2008 Nov 17. Cancer Sci. 2008. PMID: 19018772 Free PMC article.
Androgen regulation of prostate cancer: where are we now?
Corona G, Baldi E, Maggi M. Corona G, et al. J Endocrinol Invest. 2011 Mar;34(3):232-43. doi: 10.1007/BF03347072. Epub 2011 Feb 4. J Endocrinol Invest. 2011. PMID: 21297383 Review.
Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation.
Bonaccorsi L, Marchiani S, Muratori M, Forti G, Baldi E. Bonaccorsi L, et al. J Cancer Res Clin Oncol. 2004 Oct;130(10):604-14. doi: 10.1007/s00432-004-0581-8. Epub 2004 Jul 16. J Cancer Res Clin Oncol. 2004. PMID: 15258753 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program